研究業績(2011年)

論文

○Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
Ishida S, Sakamoto Y, Nishio T, Baulac S, Kuwamura M, Ohno Y, Takizawa A, Kaneko S, Serikawa T, Mashimo T.
Brain Res. 2012 Jan 30;1435:154-66. doi: 10.1016/j.brainres.2011.11.023. Epub 2011 Nov 13.

○On the likelihood of SCN1A microdeletions or duplications in Dravet syndrome with missense mutation.
Shi X, Wang J, Kurahashi H, Ishii A, Higurashi N, Kaneko S, Hirose S.
Brain Dev. 2012 Sep;34(8):617-9. doi: 10.1016/j.braindev.2011.11.005. Epub 2011 Dec 27.

○Dysfunction of extrasynaptic GABAergic transmission in phospholipase C-related, but catalytically inactive protein 1 knockout mice is associated with an epilepsy phenotype.
Zhu G, Yoshida S, Migita K, Yamada J, Mori F, Tomiyama M, Wakabayashi K, Kanematsu T, Hirata M, Kaneko S, Ueno S, Okada M.
J Pharmacol Exp Ther. 2012 Mar;340(3):520-8. doi: 10.1124/jpet.111.182386. Epub 2011 Nov 29.

○Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases.
Saruwatari J, Deguchi M, Yoshimori Y, Noai M, Yoshida S, Ogusu N, Oniki K, Yoshida S, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
Epilepsy Res. 2012 Mar;99(1-2):183-6. doi: 10.1016/j.eplepsyres.2011.10.033. Epub 2011 Nov 25.

○Selection of proper antiepileptic drugs.
Kaneko S, Yoshida S.
Rinsho Shinkeigaku. 2010 Nov;50(11):894. No abstract available.

○Remapping and mutation analysis of benign adult familial myoclonic epilepsy in a Japanese pedigree.
Mori S, Nakamura M, Yasuda T, Ueno S, Kaneko S, Sano A.
J Hum Genet. 2011 Oct;56(10):742-7. doi: 10.1038/jhg.2011.93. Epub 2011 Aug 18.

○Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome.
Sakauchi M, Oguni H, Kato I, Osawa M, Hirose S, Kaneko S, Takahashi Y, Takayama R, Fujiwara T.
Epilepsia. 2011 Jun;52(6):1144-9. doi: 10.1111/j.1528-1167.2011.03053.x. Epub 2011 Apr 11.

○Mortality in Dravet syndrome: search for risk factors in Japanese patients.
Sakauchi M, Oguni H, Kato I, Osawa M, Hirose S, Kaneko S, Takahashi Y, Takayama R, Fujiwara T.
Epilepsia. 2011 Apr;52 Suppl 2:50-4. doi: 10.1111/j.1528-1167.2011.03002.x.

○[Personalized medicine for epilepsy based on the pharmacogenomic testing].
Yoshida S, Sugawara T, Nishio T, Kaneko S.
Brain Nerve. 2011 Apr;63(4):295-9. Review. Japanese.

○Is breast-feeding of infants advisable for epileptic mothers taking antiepileptic drugs?
Chen L, Liu F, Yoshida S, Kaneko S.
Psychiatry Clin Neurosci. 2010 Oct;64(5):460-8. doi: 10.1111/j.1440-1819.2010.02126.x. Review.

○A case of neurosarcoidosis with necrotizing granuloma expressing angiotensin-converting enzyme.
Kitajima S, Sakai N, Furuichi K, Tomokage M, Hara A, Kitagawa K, Sawada Kitamura S, Zen Y, Nakada M, Kaneko S, Wada T.
Mod Rheumatol. 2010 Oct;20(5):506-10. doi: 10.1007/s10165-010-0301-y. Epub 2010 May 25.

○[Mental retardation and disturbance of cognitive function].
Kaneko S, Wada K.
Ryoikibetsu Shokogun Shirizu. 2002;(37 Pt 6):375-8. Review. Japanese. No abstract available.

○A study of ring 20 chromosome karyotype with epilepsy.
Yamadera H, Kobayashi K, Sugai K, Suda H, Kaneko S.
Psychiatry Clin Neurosci. 1998 Feb;52(1):63-8. Review.